Puma Biotechnology Inc PBYI
Morningstar Growth Grade = A
Projected Annual Return = 18%
June 23, 2021 price = $9.88
Company Profile
Business Description
Puma Biotechnology is a biotechnology company focused on developing novel therapeutics for the treatment of cancer. Puma licenses the commercial rights to its current drug candidates. The company expects to augment its product pipeline by acquiring, through license or otherwise, additional drug candidates for research and development and potential commercialization. In evaluating potential drug candidates, Puma employs disciplined decision criteria favoring drug candidates that have undergone at least some clinical study.
Contact10880 Wilshire Boulevard, Suite 2150
Los Angeles, CA, 90024
Los Angeles, CA, 90024
T +1 424 248-6500
SectorHealthcare
IndustryBiotechnology
Most Recent EarningsMar 31, 2021
Fiscal Year EndDec 31, 2021
No comments:
Post a Comment